Addus HomeCare (NASDAQ:ADUS) Given New $118.00 Price Target at Bank of America

Addus HomeCare (NASDAQ:ADUS) had its target price raised by Bank of America from $115.00 to $118.00 in a research report sent to investors on Tuesday morning, Benzinga reports. Bank of America currently has a buy rating on the stock.

Several other equities analysts have also recently commented on the stock. Royal Bank of Canada reiterated an outperform rating and set a $102.00 target price on shares of Addus HomeCare in a research note on Thursday, February 29th. Barclays lowered shares of Addus HomeCare from an equal weight rating to an underweight rating and set a $83.00 price objective for the company. in a research report on Tuesday, April 23rd. Oppenheimer reissued an outperform rating and set a $118.00 target price on shares of Addus HomeCare in a research report on Tuesday, March 26th. Finally, William Blair reaffirmed an outperform rating on shares of Addus HomeCare in a report on Monday, February 5th. One equities research analyst has rated the stock with a sell rating and eight have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of Moderate Buy and a consensus target price of $108.57.

Addus HomeCare Stock Down 0.9 %

ADUS stock opened at $106.10 on Tuesday. The company has a debt-to-equity ratio of 0.18, a current ratio of 1.38 and a quick ratio of 1.38. The company has a 50-day moving average of $99.31 and a two-hundred day moving average of $92.81. The stock has a market capitalization of $1.74 billion, a price-to-earnings ratio of 26.33, a price-to-earnings-growth ratio of 1.94 and a beta of 0.96. Addus HomeCare has a 52-week low of $78.35 and a 52-week high of $107.54.

Addus HomeCare (NASDAQ:ADUS) last announced its earnings results on Monday, May 6th. The company reported $1.21 earnings per share for the quarter, beating the consensus estimate of $0.97 by $0.24. Addus HomeCare had a return on equity of 9.70% and a net margin of 5.91%. The firm had revenue of $280.70 million during the quarter, compared to the consensus estimate of $279.49 million. During the same quarter in the prior year, the company earned $0.84 EPS. The firm’s revenue for the quarter was up 11.6% compared to the same quarter last year. As a group, equities research analysts anticipate that Addus HomeCare will post 4.38 EPS for the current year.

Institutional Investors Weigh In On Addus HomeCare

A number of institutional investors have recently added to or reduced their stakes in the stock. Principal Securities Inc. acquired a new position in shares of Addus HomeCare in the 4th quarter worth approximately $26,000. BluePath Capital Management LLC bought a new stake in Addus HomeCare in the third quarter valued at $31,000. GAMMA Investing LLC acquired a new position in Addus HomeCare during the fourth quarter worth $34,000. Assetmark Inc. raised its stake in Addus HomeCare by 17.1% during the third quarter. Assetmark Inc. now owns 1,331 shares of the company’s stock worth $113,000 after acquiring an additional 194 shares in the last quarter. Finally, DekaBank Deutsche Girozentrale bought a new position in shares of Addus HomeCare during the third quarter valued at $189,000. 95.35% of the stock is owned by institutional investors and hedge funds.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.